ProCE Banner Activity

Key Decisions in HIV Care: ART Considerations With Coinfections

Podcast Episodes
In this on-demand recording of a live webinar, expert faculty review key considerations when choosing ART for patients with coinfections including for patients with HBV/HIV and TB/HIV.

Released: January 10, 2022

Expiration: January 09, 2023

No longer available for credit.

Share

Faculty

Daria Podlekareva

Daria Podlekareva, MD, PhD

Senior Researcher
Centre of Excellence for Health, Immunity and Infections (CHIP)
Rigshospitalet, University of Copenhagen
Consultant
Department of Respiratory Medicine
Bispebjerg Hospital, University of Copenhagen
Copenhagen, Denmark

Mark S. Sulkowski

Mark S. Sulkowski, MD

Associate Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Daria Podlekareva, MD, PhD

Senior Researcher
Centre of Excellence for Health, Immunity and Infections (CHIP)
Rigshospitalet, University of Copenhagen
Consultant
Department of Respiratory Medicine
Bispebjerg Hospital, University of Copenhagen
Copenhagen, Denmark

Daria Podlekareva, MD, PhD, has no relevant conflicts of interest to report.

Mark S. Sulkowski, MD

Associate Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Mark S. Sulkowski, MD, has disclosed that he has received funds for research support from AbbVie, Assembly Bio, Gilead Sciences, and Janssen and consulting fees from AbbVie, Antios, Arbutus, Assembly Bio, Gilead Sciences, ViiV, and Virion.